Meta-analysis of FK 506 and mycophenolate mofetil refractory rejection trials in renal transplantation. Refractory Rejection Meta-Analysis Study Group

scientific article published on 01 June 1998

Meta-analysis of FK 506 and mycophenolate mofetil refractory rejection trials in renal transplantation. Refractory Rejection Meta-Analysis Study Group is …
instance of (P31):
scholarly articleQ13442814
meta-analysisQ815382

External links are
P356DOI10.1016/S0041-1345(98)00249-8
P698PubMed publication ID9636526

P50authorErvin WoodleQ73677442
P2093author name stringR Shapiro
M L Jordan
G M Danovitch
D Facklam
P2860cites workTacrolimus rescue therapy for renal allograft rejection--five-year experienceQ34315266
A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study GroupQ71588915
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectmeta-analysisQ815382
P304page(s)1297-1298
P577publication date1998-06-01
P1433published inTransplantation ProceedingsQ7834825
P1476titleMeta-analysis of FK 506 and mycophenolate mofetil refractory rejection trials in renal transplantation. Refractory Rejection Meta-Analysis Study Group
P478volume30

Reverse relations

cites work (P2860)
Q48933429Forty years of publication of transplantation proceedings-the third decade: the expansion of the enterprise
Q34275879Outcome of tacrolimus conversion therapy for renal allograft rejection: 5-year follow-up
Q33957200The use of mycophenolate mofetil in transplant recipients

Search more.